Literature DB >> 26067125

Lower urinary tract dysfunction in the neurological patient: clinical assessment and management.

Jalesh N Panicker1, Clare J Fowler2, Thomas M Kessler3.   

Abstract

Lower urinary tract (LUT) dysfunction is a common sequela of neurological disease, resulting in symptoms that have a pronounced effect on quality of life. The site and nature of the neurological lesion affect the pattern of dysfunction. The risk of developing upper urinary tract damage and renal failure is much lower in patients with slowly progressive non-traumatic neurological disorders than in those with spinal cord injury or spina bifida; this difference in morbidity is taken into account in the development of appropriate management algorithms. Clinical assessment might include tests such as uroflowmetry, post-void residual volume measurement, renal ultrasound, (video-)urodynamics, neurophysiology, and urethrocystoscopy, depending on the indication. Incomplete bladder emptying is most often managed by intermittent catheterisation, and storage dysfunction by antimuscarinic drugs. Intradetrusor injections of onabotulinumtoxinA have transformed the management of neurogenic detrusor overactivity. Neuromodulation offers promise for managing both storage and voiding dysfunction. An individualised, patient-tailored approach is required for the management of LUT dysfunction associated with neurological disorders.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26067125     DOI: 10.1016/S1474-4422(15)00070-8

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  71 in total

1.  Nocturia in Patients With Multiple Sclerosis.

Authors:  Benoit Peyronnet; Lauren B Krupp; W Stuart Reynolds; Xavier Gamé; Gérard Amarenco; Jean-Nicolas Cornu; Lana Zhovtis Ryerson; Carrie Lyn Sammarco; Jonathan E Howard; Robert W Charlson; Roger R Dmochowski; Benjamin M Brucker
Journal:  Rev Urol       Date:  2019

2.  Urinary retention and catheter use among U.S. female Medicare beneficiaries: Prevalence and risk factors.

Authors:  Joshua A Cohn; Shenghua Ni; Melissa R Kaufman; Amy J Graves; David F Penson; Roger R Dmochowski; W Stuart Reynolds
Journal:  Neurourol Urodyn       Date:  2017-03-07       Impact factor: 2.696

3.  Canadian Urological Association guideline: Diagnosis, management, and surveillance of neurogenic lower urinary tract dysfunction - Executive summary.

Authors:  Alex Kavanagh; Richard Baverstock; Lysanne Campeau; Kevin Carlson; Ashley Cox; Duane Hickling; Genviève Nadeau; Lynn Stothers; Blayne Welk
Journal:  Can Urol Assoc J       Date:  2019-06       Impact factor: 1.862

Review 4.  Early urological care of patients with spinal cord injury.

Authors:  Blayne Welk; Marc P Schneider; Jeffrey Thavaseelan; Luca R Traini; Armin Curt; Thomas M Kessler
Journal:  World J Urol       Date:  2018-06-09       Impact factor: 4.226

5.  Identifying barriers to help-seeking for sexual dysfunction in multiple sclerosis.

Authors:  Katarina Ivana Tudor; S Eames; C Haslam; J Chataway; M D Liechti; J N Panicker
Journal:  J Neurol       Date:  2018-09-19       Impact factor: 4.849

Review 6.  Neurogenic lower urinary tract dysfunction: evaluation and management.

Authors:  Katarina Ivana Tudor; Ryuji Sakakibara; Jalesh N Panicker
Journal:  J Neurol       Date:  2016-07-11       Impact factor: 4.849

7.  Is Pelvic Floor Muscle Training Effective for Men With Poststroke Lower Urinary Tract Symptoms? A Single-Blinded Randomized, Controlled Trial.

Authors:  Sigrid Tibaek; Gunvor Gard; Christian Dehlendorff; Helle K Iversen; Fin Biering-Soerensen; Rigmor Jensen
Journal:  Am J Mens Health       Date:  2015-10-18

Review 8.  How botulinum toxin in neurogenic detrusor overactivity can reduce upper urinary tract damage?

Authors:  Maximilien Baron; Philippe Grise; Jean-Nicolas Cornu
Journal:  World J Nephrol       Date:  2016-03-06

9.  Functional Magnetic Resonance Imaging with Concurrent Urodynamic Testing Identifies Brain Structures Involved in Micturition Cycle in Patients with Multiple Sclerosis.

Authors:  Rose Khavari; Christof Karmonik; Michael Shy; Sophie Fletcher; Timothy Boone
Journal:  J Urol       Date:  2016-09-21       Impact factor: 7.450

10.  Outcomes following percutaneous tibial nerve stimulation (PTNS) treatment for neurogenic and idiopathic overactive bladder.

Authors:  Katarina Ivana Tudor; Jai H Seth; Martina D Liechti; Juliana Ochulor; Gwen Gonzales; Collette Haslam; Zoe Fox; Mahreen Pakzad; Jalesh N Panicker
Journal:  Clin Auton Res       Date:  2018-08-03       Impact factor: 4.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.